Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 9,648 $ 2,647
Accounts receivable, net 14,720 12,097
Inventories 3,001 2,899
Other current assets 2,402 1,662
Total current assets 29,771 19,305
Medical equipment for sale or rental 1,603 1,306
Medical equipment in rental service, net of accumulated depreciation 35,611 33,225
Property & equipment, net of accumulated depreciation 4,296 4,037
Intangible assets, net 11,177 15,463
Operating lease right of use assets 4,461 5,733
Deferred income taxes 9,967
Other assets 105 155
Total assets 96,991 79,224
Current liabilities:    
Accounts payable 6,779 7,962
Current portion of long-term debt 9,423 8,082
Other current liabilities 6,795 5,803
Total current liabilities 22,997 21,847
Long-term debt, net of current portion 29,378 30,295
Deferred income taxes 104
Operating lease liabilities, net of current portion 3,864 4,644
Total liabilities 56,239 56,890
Stockholders’ equity:    
Preferred stock, $.0001 par value: authorized 1,000,000 shares; none issued
Common stock, $.0001 par value: authorized 200,000,000 shares; issued and outstanding 23,816,193 and 20,297,704, as of December 31, 2020, respectively, and issued and outstanding 23,400,625 and 19,882,136, as of December 31, 2019, respectively. 2 2
Additional paid-in capital 84,785 83,699
Retained deficit (44,035) (61,367)
Total stockholders’ equity 40,752 22,334
Total liabilities and stockholders’ equity $ 96,991 $ 79,224